Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gillessen

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2026
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancerS Gillessen, E Gallardo, A Choudhury, et al.
European Urology Oncology|March 20, 2026
Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14)S Gillessen, K Gobat, R Cathomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancerC J Pezaro, A Omlin, K Mastris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2023
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancerP A Sutera, A C Shetty, A Hakansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2026
Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upK Fizazi, G Attard, A A Azad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2018
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-upF Honecker, J Aparicio, D Berney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2018
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocolM R Sydes, M R Spears, M D Mason, et al.
Physical Review Letters|April 2, 2019
Test of the Einstein Equivalence Principle near the Galactic Center Supermassive Black HoleA Amorim, M Bauböck, J P Berger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015S Gillessen, A Omlin, G Attard, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2026
Final overall survival results from EORTC 1333/PEACE-3 trial of enzalutamide plus radium-223 in metastatic castration-resistant prostate cancerS Gillessen, E Gallardo, A Choudhury, et al.
European Urology Oncology|March 20, 2026
Enzalutamide Plus Metformin Versus Enzalutamide Alone in Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 2 Trial (SAKK 08/14)S Gillessen, K Gobat, R Cathomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancerC J Pezaro, A Omlin, K Mastris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2023
Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancerP A Sutera, A C Shetty, A Hakansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2026
Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upK Fizazi, G Attard, A A Azad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2018
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-upF Honecker, J Aparicio, D Berney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trialN W Clarke, A Ali, F C Ingleby, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2018
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocolM R Sydes, M R Spears, M D Mason, et al.
Physical Review Letters|April 2, 2019
Test of the Einstein Equivalence Principle near the Galactic Center Supermassive Black HoleA Amorim, M Bauböck, J P Berger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015S Gillessen, A Omlin, G Attard, et al.
Pageof 10